RxDoctor Payments DataLook up a doctor →

Joshua Zeichner, MD

Dermatology · New York, NYNPI 1518125798

Payments from drug & device makers

$2,140,643in general payments, 2019–2025

Across 3,100 payments — averaging $690.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$362K
  • Regeneron Healthcare Solutions, Inc.$269K
  • Dermavant Sciences, Inc.$191K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$157K
  • UCB, Inc.$157K
  • Incyte Corporation$156K
  • plus $849K from 35 others

What the payments were for

  • Consulting fees$316,64115%
  • Speaking & faculty fees$1,638,09377%
  • Travel & lodging$128,3016%
  • Food & beverage$57,3153%
  • Education$2930%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,140,643 in reported general payments places this provider in the 95th percentile of 1,151 dermatology providers in New York.

See all dermatology providers in New York

Medicare billing

Part B allowed, 2024
$241,895
Medicare patients
435
Services billed
2,028

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa12$240,566
Ketoconazole94$7,877
Pimecrolimus22$7,611
Fluorouracil71$3,908
Ammonium Lactate256$3,654
Ivermectin12$1,910
Clobetasol Propionate46$1,547
Metronidazole18$1,200
ValacyclovirValacyclovir Hcl25$900
Fluticasone Propionate46$850
Tretinoin23$790
Clindamycin Phosphate21$765
Doxycycline Hyclate41$725
Minoxidil57$673
Triamcinolone Acetonide42$613

Paid to pharmacies, not to this prescriber.

Other dermatology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →